Who We Are
Who We Are
We build, test, and deliver new therapies to cure congenital heart defects, allowing families to live full, enriching lives.
Learn More
Our Story Our People Partnerships News/Blog
Our Work
Our Work
HeartWorks builds, tests, and delivers new therapies to cure congenital heart defects giving these families the opportunity to live full, enriching lives.
Learn More
We Build Hearts Lab Tours Stories The Co-op at HeartWorks
For Families
For Families
Families are the heart of HeartWorks. We work for the 1 in 100 impacted by congenital heart defects.
Learn More
Lab Tours One Heart by HeartWorks Family Team Pages The Co-op at HeartWorks
Get Involved
Get Involved
HeartWorks relies on our community to help fund the research and clinical trials that hope to find cures for congenital heart defects (CHD). Discover ways that you can help.
Learn More
Donate Donors Job Openings Events Shop Contact Us
Clinical Trials
Clinical Trials
HeartWorks is leading the world’s largest effort to develop new treatment options for CHD patients.
Learn More
Current Trials Clinical Trial Results Lab Tours
The Co-op
Donate

News & Blog

HeartWorks + Ashley Home Stores

Ashley is proud to partner with HeartWorks through the support of Ashley’s President and CEO, Todd Wanek and his wife Karen. Their philanthropic contributions have helped accelerate the expansion of the HeartWorks network and progress towards a cure for Congenital Heart Disease (CHD).

Share the Post:

Related Posts

catheter-based cardiac cell delivery technology

One Step Closer: HeartWorks Partners with SmartCella to Advance Cardiac Cell Delivery

Manufacturing personalized cardiac cells is one challenge. Getting them safely into the heart is another. HeartWorks has entered a licensing agreement with SmartCella, a Sweden-based biotech company, for its Extroducer® — a minimally invasive, catheter-based platform that could deliver cardiac cells directly to heart muscle without the need for open-heart surgery. Lab testing showed that our cardiac lineage cells maintained high viability through the delivery process, a key early milestone. Combined with reaching our first 100 biopsy participants, this partnership represents meaningful progress on the path to personalized CHD treatment.

Read More
Lori Riess and Drew Narwold, HeartWorks team members supporting The Co-op patient-driven research platform for congenital heart disease

Lori & Drew: Maximizing the Potential of the Co-op

Behind every patient who joins The Co-op @ HeartWorks, there’s a team making sure the
process is simple, the experience is supportive, and the information shared actually drives
research forward.
Meet two of the people making that happen:
Lori Reiss, Co-op Coordinator, is a personal point of contact for families who want to learn more,
get started, or simply have questions about what participation looks like. Drew Narwold works
behind the scenes to organize and analyze the data participants share — including helping
HeartWorks make smarter decisions about manufacturing personalized cardiac cells for our first
100 participants.
Together, they’re helping close the gap between patient experiences and scientific progress.

Read More

Send A Message

This field is for validation purposes and should be left unchanged.
Name(Required)
Please let us know what's on your mind. Have a question for us? Ask away.